CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

Resilience and Lilly to increase US medicines production with $750m investment

PartnershipKwikPenPositive
AI Analysis

Summary

Eli Lilly and Resilience announced a $750 million investment partnership to increase US production capacity of Lilly's KwikPen for diabetes and obesity medicines.

Importance:6/10
Sentiment:
0.70
manufacturingcapacity expansionUS productiondiabetesobesitypartnership
Related Companies

Read the original article

Published by Pharmaceutical Technology on July 31, 2026 8:00 AM

Read Original